Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 1.00 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 1.00 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 1.00 |
| ▸ | CES2 | O00748 | 1/20 | 0.70 |
| ▸ | CES1 | P23141 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | GSK3B | P49841 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.55 |
| ▸ | NPC1 | O15118 | 3/20 | 0.55 |
| ▸ | RAB9A | P51151 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | PKM | P14618 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.52 |
| ▸ | KDM6B | O15054 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Picolinic Acid SCHEMBL36055 | 1.00 | — | — | |
| 2-Picolinic Acid SCHEMBL28737810 | 1.00 | LMNA (1.00) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL29368665 | 1.00 | — | — | |
| 2-Picolinic Acid SCHEMBL7457912 | 1.00 | LMNA (1.00) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL12537807 | 0.98 | LMNA (0.95) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL5058102 | 0.98 | LMNA (0.95) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL1462616 | 0.98 | LMNA (0.95) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL22835776 | 0.98 | LMNA (0.95) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL20721125 | 0.98 | LMNA (0.95) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL149849 | 0.98 | LMNA (0.95) | LMNAL3MBTL1NAPRTP4HTMCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110110913-A1 | PHARMACEUTICAL FORMULATIONS OF RESVERATROL AND METHODS OF USE THEREOF FOR TREATING CELL DISORDERS | NAD LIFE PTY LTD (AU) | 2011-05-12 | — | — | US | claimed |
| JP-2011513338-A | — | — | 2011-04-28 | — | — | JP | claimed |
| CN-120157659-A | Heterocyclic compound, organic light-emitting device comprising same, and composition for organic material layer | LT素材株式会社 | 2025-06-17 | — | — | CN | disclosed |
| WO-2020253696-A1 | SUBSTITUTED PYRIDINEMETHYLENE PYRIDINECARBOXYLATE DERIVATIVE, PREPARATION METHOD THEREFOR AND HERBICIDAL COMPOSITION AND USE THEREOF | 青岛清原化合物有限公司 | 2020-12-24 | — | — | WO | disclosed |
| CN-111925357-A | Acylhydrazone compound, pharmaceutical composition and application thereof | 中国科学院昆明植物研究所 | 2020-11-13 | — | — | CN | disclosed |
| US-20190214145-A1 | Method and systems for creating and screening patient metabolite profile to diagnose current medical condition, diagnose current treatment state and recommend new treatment regimen | KUREK ITZHAK (US) | 2019-07-11 | — | — | US | disclosed |
| CN-109251168-A | A method of pyridine -2- formic acid is prepared using 2-OP rectification residue | 盐城工学院 | 2019-01-22 | — | — | CN | disclosed |
| WO-2018005258-A1 | CONDITIONER COMPOSITION COMPRISING A CHELANT | THE PROCTER & GAMBLE COMPANY (US) | 2018-01-04 | — | — | WO | disclosed |
| WO-2018005257-A1 | SHAMPOO COMPOSITIONS COMPRISING A CHELANT | THE PROCTER & GAMBLE COMPANY (US) | 2018-01-04 | — | — | WO | disclosed |
| CN-106148276-A | Application in the medicine of preparation treatment nerve degenerative diseases for the mescenchymal stem cell | 中国科学院上海生命科学研究院 | 2016-11-23 | — | — | CN | disclosed |
| CN-104402816-A | Benzo picolinic acid synthesis method | UNIV CHANGZHOU | 2015-03-11 | — | — | CN | disclosed |
| WO-2011087786-A1 | HYDROGEN PEROXIDE COMPOSITIONS AND CLEANING FORMULATIONS PREPARED THEREFROM | ARKEMA INC. (US) | 2011-07-21 | — | — | WO | disclosed |
| US-20110136157-A1 | Copper regulation evaluation and therapy | PHILERA NEW ZEALAND LIMITED (NZ) | 2011-06-09 | — | — | US | disclosed |
| US-20110110913-A1 | PHARMACEUTICAL FORMULATIONS OF RESVERATROL AND METHODS OF USE THEREOF FOR TREATING CELL DISORDERS | NAD LIFE PTY LTD (AU) | 2011-05-12 | — | — | US | disclosed |
| WO-2011002939-A1 | CHROMIUM COMPLEXES AS ENHANCERS OF BRAIN GLUCOSE TRANSPORTERS | NUTRITION 21, INC. (US) | 2011-01-06 | — | — | WO | disclosed |
| EP-2207774-A1 | TRIAZOLE DERIVATIVES AS SCD INHIBITORS | GlaxoSmithKline LLC (US) | 2010-07-21 | — | — | EP | disclosed |
| WO-2009060054-A1 | TRIAZOLE DERIVATIVES AS SCD INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2009-05-14 | — | — | WO | disclosed |
| EP-0527186-A4 | — | UNIV ILLINOIS (US) | 1995-01-18 | — | — | EP | disclosed |
| EP-0527186-A1 | PHOTODYNAMIC PLANT DEFOLIANTS AND CHLOROPHYLL BIOSYNTHESIS MODULATORS | The Board of Trustees for the University of Illinois (US) | 1993-02-17 | — | — | EP | disclosed |
| WO-1991016820-A1 | PHOTODYNAMIC PLANT DEFOLIANTS AND CHLOROPHYLL BIOSYNTHESIS MODULATORS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1991-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110110913-A1 | PHARMACEUTICAL FORMULATIONS OF RESVERATROL AND METHODS OF USE THEREOF FOR TREATING CELL DISORDERS | SIRT1, SIRT2, SIRT6 | LMNA 1009/4885L3MBTL1 3867/4885NAPRT 83/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.